NCT05469178 2025-10-29A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 GeneBerGenBio ASAPhase 1/2 Terminated26 enrolled 13 charts